{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T12:07:55Z","timestamp":1788782875513,"version":"build-2803163510"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surveyophthalmol.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Survey of Ophthalmology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.survophthal.2026.07.009","type":"journal-article","created":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T20:05:55Z","timestamp":1785701155000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["The efficacy and safety of adeno-associated virus-mediated gene therapy for CNGA3- and CNGB3-associated achromatopsia: A genotype-aware systematic review and meta-analysis"],"prefix":"10.1016","author":[{"given":"Kai-Yang","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoi-Chun","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6981-3411","authenticated-orcid":false,"given":"Chi-Ming","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.survophthal.2026.07.009_bib1","article-title":"A review on achromatopsia: exploring genetic basis, diagnostic innovations, and therapeutic prospects","volume":"8","author":"Jee","year":"2025","journal-title":"Multidiscip Rev"},{"key":"10.1016\/j.survophthal.2026.07.009_bib2","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.718958","article-title":"Structural differences across multiple visual cortical regions in the absence of cone function in congenital achromatopsia","volume":"15","author":"Lowndes","year":"2021","journal-title":"Front Neurosci"},{"key":"10.1016\/j.survophthal.2026.07.009_bib3","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1177\/11206721231212768","article-title":"Achromatopsia: long term visual performance and clinical characteristics","volume":"34","author":"Eshel","year":"2024","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.survophthal.2026.07.009_bib4","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.3390\/ijms22041681","article-title":"Clinical and molecular characterization of achromatopsia patients: a longitudinal study","volume":"22","author":"Brunetti-Pierri","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.survophthal.2026.07.009_bib5","article-title":"Achromatopsia","author":"Kohl","year":"1993","journal-title":"GeneReviews"},{"key":"10.1016\/j.survophthal.2026.07.009_bib6","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s11910-021-01137-8","article-title":"Color vision deficits","volume":"21","author":"Bartolomeo","year":"2021","journal-title":"Curr Neurol Neurosci Rep"},{"key":"10.1016\/j.survophthal.2026.07.009_bib7","doi-asserted-by":"crossref","first-page":"690","DOI":"10.3390\/genes14030690","article-title":"Genetic and clinical characterization of Danish achromatopsia patients","volume":"14","author":"Andersen","year":"2023","journal-title":"Genes"},{"key":"10.1016\/j.survophthal.2026.07.009_bib8","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/ceo.14511","article-title":"Monogenic retinal diseases associated with genes encoding phototransduction proteins: a review","volume":"53","author":"Wong","year":"2025","journal-title":"Clin & Exp Ophthalmol"},{"key":"10.1016\/j.survophthal.2026.07.009_bib9","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1093\/hmg\/9.14.2107","article-title":"Mutations in the CNGB3 gene encoding the \u03b2-subunit of the cone photoreceptor cGMP-gated channel are responsible for achromatopsia (ACHM3) linked to chromosome 8q21","volume":"9","author":"Kohl","year":"2000","journal-title":"Human Mol Genet"},{"key":"10.1016\/j.survophthal.2026.07.009_bib10","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1002\/humu.20790","article-title":"Mutations in CNGA3 impair trafficking or function of cone cyclic nucleotide-gated channels, resulting in achromatopsia","volume":"29","author":"Reuter","year":"2008","journal-title":"Human Mutat"},{"key":"10.1016\/j.survophthal.2026.07.009_bib11","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1086\/323613","article-title":"CNGA3 mutations in hereditary cone photoreceptor disorders","volume":"69","author":"Wissinger","year":"2001","journal-title":"Am J Human Genet"},{"key":"10.1016\/j.survophthal.2026.07.009_bib12","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1097\/OPX.0000000000002143","article-title":"Vision-related quality of life, photoaversion, and optical rehabilitation in achromatopsia","volume":"101","author":"Andersen","year":"2024","journal-title":"Optom Vision Sci"},{"key":"10.1016\/j.survophthal.2026.07.009_bib13","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/s41434-020-0168-2","article-title":"Retinal gene therapy: an eye-opener of the 21st century","volume":"28","author":"Askou","year":"2021","journal-title":"Gene Ther"},{"key":"10.1016\/j.survophthal.2026.07.009_bib14","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.3390\/biomedicines12071523","article-title":"Recombinant adeno-associated virus vectors for gene therapy of the central nervous system: delivery routes and clinical aspects","volume":"12","author":"S\u0142yk","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.survophthal.2026.07.009_bib15","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1007\/s10792-021-01717-0","article-title":"Gene therapy in color vision deficiency: a review","volume":"41","author":"El Moussawi","year":"2021","journal-title":"Int Ophthalmol"},{"key":"10.1016\/j.survophthal.2026.07.009_bib16","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s40291-021-00565-z","article-title":"Achromatopsia: genetics and gene therapy","volume":"26","author":"Michalakis","year":"2022","journal-title":"Mol Diagn & Ther"},{"issue":"3","key":"10.1016\/j.survophthal.2026.07.009_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109022","article-title":"Restoration of visual function in advanced disease after transplantation of purified human pluripotent stem cell-derived cone photoreceptors","volume":"35","author":"Ribeiro","year":"2021","journal-title":"Cell Rep"},{"key":"10.1016\/j.survophthal.2026.07.009_bib18","series-title":"Structural retinal and visual cortex phenotyping and gene therapy in achromatopsia. PhD thesis","author":"Katta","year":"2024"},{"key":"10.1016\/j.survophthal.2026.07.009_bib19","doi-asserted-by":"crossref","first-page":"9739","DOI":"10.3390\/ijms25179739","article-title":"Gene therapy for achromatopsia","volume":"25","author":"Baxter","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"6","key":"10.1016\/j.survophthal.2026.07.009_bib20","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1001\/jamaophthalmol.2020.1032","article-title":"Safety and vision outcomes of subretinal gene therapy targeting cone photoreceptors in achromatopsia: a nonrandomized controlled trial","volume":"138","author":"Fischer","year":"2020","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.survophthal.2026.07.009_bib21","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1136\/bjophthalmol-2021-319067","article-title":"Three-year results of phase I retinal gene therapy trial for CNGA3-mutated achromatopsia: results of a non randomised controlled trial","volume":"106","author":"Reichel","year":"2022","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2026.07.009_bib22","doi-asserted-by":"crossref","first-page":"3803","DOI":"10.1093\/brain\/awac226","article-title":"A demonstration of cone function plasticity after gene therapy in achromatopsia","volume":"145","author":"Farahbakhsh","year":"2022","journal-title":"Brain"},{"key":"10.1016\/j.survophthal.2026.07.009_bib23","doi-asserted-by":"crossref","first-page":"3489","DOI":"10.1016\/j.cub.2023.06.041","article-title":"Seeing color following gene augmentation therapy in achromatopsia","volume":"33","author":"McKyton","year":"2023","journal-title":"Curr Biol"},{"key":"10.1016\/j.survophthal.2026.07.009_bib24","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s13643-021-01626-4","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"10","author":"Page","year":"2021","journal-title":"Syst Rev"},{"key":"10.1016\/j.survophthal.2026.07.009_bib25","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1167\/tvst.14.2.9","article-title":"Visual tract integrity before and after gene therapy in congenital achromatopsia","volume":"14","author":"Abramovitch","year":"2025","journal-title":"Transl Vis Sci Technol"},{"key":"10.1016\/j.survophthal.2026.07.009_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainresbull.2024.111026","article-title":"fMRI and gene therapy in adults with CNGB3 mutation","volume":"215","author":"Anderson","year":"2024","journal-title":"Brain Res Bull"},{"issue":"35","key":"10.1016\/j.survophthal.2026.07.009_bib27","first-page":"7363","article-title":"Cortical visual mapping following ocular gene augmentation therapy for achromatopsia","volume":"41","author":"McKyton","year":"2021","journal-title":"J Neurosci"},{"key":"10.1016\/j.survophthal.2026.07.009_bib28","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.ajo.2023.05.009","article-title":"First-in-human gene therapy trial of AAV8-hCARp.hCNGB3 in Adults and Children with CNGB3-associated Achromatopsia","volume":"253","author":"Michaelides","year":"2023","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"10.1016\/j.survophthal.2026.07.009_bib29","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1167\/iovs.17-22494","article-title":"Humoral immune response after intravitreal but not after subretinal AAV8 in primates and patients","volume":"59","author":"Reichel","year":"2018","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2026.07.009_bib30","first-page":"452","article-title":"Neural plasticity of the human visual system reflects treatment effect in gene therapy for Achromatopsia","volume":"63","author":"Seitz","year":"2022","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2026.07.009_bib31","first-page":"3289","article-title":"Photoreceptor structure following gene therapy in CNGA3-mediated Achromatopsia: adaptive optics imaging results from a Phase 1\/2 dose escalation clinical trial for AGTC-402 (rAAV2tYF-PR1.7-hCNGA3)","volume":"65","author":"Jiang","year":"2024","journal-title":"Invest Ophthalmol & Vis Sci"},{"key":"10.1016\/j.survophthal.2026.07.009_bib32","first-page":"2921","article-title":"Effects of subretinal AAV8 gene therapy on microperimetry in CNGA3 achromatopsia patients","volume":"60","author":"Ochakovski","year":"2019","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2026.07.009_bib33","first-page":"4678","article-title":"How do patients rate their subjective symptoms after CNGA3 gene therapy: First application of the instrument A3-PRO","volume":"58","author":"Wilhelm","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2026.07.009_bib34","series-title":"Neurodegenerative Diseases: Translational Models, Mechanisms, and Therapeutics","first-page":"202","article-title":"Gene Therapy, OMICS Approaches, and Translational Neurodegenerative Models: Recent Advancements and Future Perspectives","author":"Sharma","year":"2025"},{"issue":"28","key":"10.1016\/j.survophthal.2026.07.009_bib35","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2024448118","article-title":"Shifting gradients of macroscale cortical organization mark the transition from childhood to adolescence","volume":"118","author":"Dong","year":"2021","journal-title":"Proc Natl Acad Sci"}],"container-title":["Survey of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039625726001074?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039625726001074?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T11:15:53Z","timestamp":1788779753000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039625726001074"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":35,"alternative-id":["S0039625726001074"],"URL":"https:\/\/doi.org\/10.1016\/j.survophthal.2026.07.009","relation":{},"ISSN":["0039-6257"],"issn-type":[{"value":"0039-6257","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The efficacy and safety of adeno-associated virus-mediated gene therapy for CNGA3- and CNGB3-associated achromatopsia: A genotype-aware systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Survey of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.survophthal.2026.07.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}